Literature DB >> 19438661

Recurrence of lentigo maligna and development of invasive melanoma after treatment of lentigo maligna with imiquimod.

Courtney S Woodmansee1, Michael W McCall.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19438661     DOI： 10.1111/j.1524-4725.2009.01227.x

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN： 1076-0512            Impact factor:   3.398


× No keyword cloud information.
  4 in total

1.  Toll-like receptors and cutaneous melanoma.

Authors:  Ilaria Coati; Serena Miotto; Irene Zanetti; Mauro Alaibac
Journal:  Oncol Lett       Date:  2016-09-21       Impact factor: 2.967

2.  Combination therapy of imiquimod and gentian violet for cutaneous melanoma metastases.

Authors:  Jack L Arbiser; Maria Bips; Anne Seidler; Michael Y Bonner; Charles Kovach
Journal:  J Am Acad Dermatol       Date:  2012-08       Impact factor: 11.527

Review 3.  Diagnosis and management of lentigo maligna: a review.

Authors:  Julia M Kasprzak; Yaohui G Xu
Journal:  Drugs Context       Date:  2015-05-29

4.  The effect of imiquimod on matrix metalloproteinases and tissue inhibitors of metalloproteinases in malignant melanoma cell invasion.

Authors:  Jin Young Jung; Hyun Sook Kim; Mi Ryung Roh; Hyo Jin Roh; Sang Yoon Lee; Kee Yang Chung
Journal:  Ann Dermatol       Date:  2014-06-12       Impact factor: 1.444
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.